Rucaparib maintenance in ATHENA-MONO (GOG-3020/ENGOT-ov45) in patients with newly diagnosed advanced ovarian cancer: exploratory post-progression evaluations for patients with HRD-negative and HRD-unknown tumours

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Flora Zagouri, John Paul Diaz, Xing Zeng, Purificación Martinez- Del Prado, Andrea Jewell, Vanda Salutari, Linda Van Le, Chien-Hsing Lu, Oğuzhan Kuru, Leslie Siriya Bradford, Anita Monika Chudecka-Glaz, William Hampton Bradley
+7 more Dearbhaile Catherine Collins, R. W. Holloway, Jen Borrow, Valerie Shu Fei. Ong, Keiichi Fujiwara, Rebecca Sophie Kristeleit, Bradley J. Monk
DOI: 10.1016/j.ijgc.2025.103090
Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment BRCA gene mutations in cancer

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103090–103090
Publication date
1 February 2026
Language
EN